Literature DB >> 21833830

Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment.

Nikola Minovski1, Andrej Perdih, Tom Solmajer.   

Abstract

The virtual combinatorial chemistry approach as a methodology for generating chemical libraries of structurally-similar analogs in a virtual environment was employed for building a general mixed virtual combinatorial library with a total of 53.871 6-FQ structural analogs, introducing the real synthetic pathways of three well known 6-FQ inhibitors. The druggability properties of the generated combinatorial 6-FQs were assessed using an in-house developed drug-likeness filter integrating the Lipinski/Veber rule-sets. The compounds recognized as drug-like were used as an external set for prediction of the biological activity values using a neural-networks (NN) model based on an experimentally-determined set of active 6-FQs. Furthermore, a subset of compounds was extracted from the pool of drug-like 6-FQs, with predicted biological activity, and subsequently used in virtual screening (VS) campaign combining pharmacophore modeling and molecular docking studies. This complex scheme, a powerful combination of chemometric and molecular modeling approaches provided novel QSAR guidelines that could aid in the further lead development of 6-FQs agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833830     DOI: 10.1007/s00894-011-1179-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  39 in total

1.  Combinatorial chemistry and high-throughput screening in drug discovery: different strategies and formats.

Authors:  P Seneci; S Miertus
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

Review 2.  Chemical space navigation in lead discovery.

Authors:  Tudor I Oprea
Journal:  Curr Opin Chem Biol       Date:  2002-06       Impact factor: 8.822

3.  A 'rule of three' for fragment-based lead discovery?

Authors:  Miles Congreve; Robin Carr; Chris Murray; Harren Jhoti
Journal:  Drug Discov Today       Date:  2003-10-01       Impact factor: 7.851

Review 4.  Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?

Authors:  Johannes Kirchmair; Patrick Markt; Simona Distinto; Gerhard Wolber; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2008-01-15       Impact factor: 3.686

5.  Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).

Authors:  F M Barnard; A Maxwell
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

6.  Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.

Authors:  Sergio Madurga; Javier Sánchez-Céspedes; Ignasi Belda; Jordi Vila; Ernest Giralt
Journal:  Chembiochem       Date:  2008-09-01       Impact factor: 3.164

Review 7.  DNA gyrase: structure and function.

Authors:  R J Reece; A Maxwell
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

8.  Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.

Authors:  A Kitamura; K Hoshino; Y Kimura; I Hayakawa; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

Review 9.  Patient adherence to tuberculosis treatment: a systematic review of qualitative research.

Authors:  Salla A Munro; Simon A Lewin; Helen J Smith; Mark E Engel; Atle Fretheim; Jimmy Volmink
Journal:  PLoS Med       Date:  2007-07-24       Impact factor: 11.069

Review 10.  Tuberculosis chemotherapy: current drug delivery approaches.

Authors:  Lisa Claire du Toit; Viness Pillay; Michael Paul Danckwerts
Journal:  Respir Res       Date:  2006-09-19
View more
  1 in total

1.  Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor with Benzoxazine Acetamide Scaffold.

Authors:  Samia A Elseginy; Manal M Anwar
Journal:  ACS Omega       Date:  2021-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.